355
The journal Thérapie has published an article about Type 1 Gaucher disease. Type 1 Gaucher disease is a rare genetic disease characterized by enzymatic deficit leading to glucosylceramide overload in body tissues (lysosomal overload disease). Standard treatment is based on substitutive enzyme therapy by intravenous perfusion. The full-text article you can find here.